Arvest Bank Trust Division’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-109,720
Closed -$9.79M 139
2018
Q1
$9.79M Sell
109,720
-610
-0.6% -$58.6K 0.69% 51
2017
Q4
$11.5M Sell
110,330
-4,228
-4% -$477K 0.8% 45
2017
Q3
$16.7M Buy
114,558
+693
+0.6% +$94.4K 1.19% 28
2017
Q2
$14.8M Buy
113,865
+1,681
+1% +$206K 1.12% 32
2017
Q1
$14M Sell
112,184
-2,483
-2% -$297K 1.09% 37
2016
Q4
$13.3M Buy
114,667
+134
+0.1% +$14.9K 1.06% 39
2016
Q3
$12M Buy
+114,533
New +$12.4M 0.99% 43

Other funds holding CELG

Arvest Bank Trust Division's CELG Position: Q2 2018 in Review

Arvest Bank Trust Division sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 109,720 shares — an estimated $9.79M sold.

Arvest Bank Trust Division first reported a position in CELG in Q3 2016 and held it in 7 quarters. The position peaked at $16.7M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Arvest Bank Trust Division reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Arvest Bank Trust Division sold 109,720 Celgene Corp shares in Q2 2018, an estimated $9.79M.
  • Arvest Bank Trust Division first reported a position in Celgene Corp in Q3 2016 and held it in 7 quarters.
  • Arvest Bank Trust Division's Celgene Corp position peaked at $16.7M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Arvest Bank Trust Division's 13F filing for Q2 2018, filed 18 Jul 2018.